What is Univfy?
Univfy operates at the intersection of reproductive medicine and data science, providing sophisticated predictive analytics for IVF success and cost management. The company's flagship offering, the Univfy PreIVF Report, empowers patients with personalized probability assessments, effectively demystifying the financial and medical complexities of fertility treatments. By collaborating with fertility specialists to implement innovative refund programs and multi-cycle discounts, Univfy is actively transforming the patient experience. The firm's market position is defined by its ability to integrate clinical outcomes with financial planning, thereby increasing accessibility and patient satisfaction in a high-stakes healthcare segment.
How much funding has Univfy raised?
Univfy has raised a total of $16.2M across 5 funding rounds:
Angel/Seed
$3.8M
Series A
$6M
Debt
$150K
Debt
$252K
Series B
$6M
Angel/Seed (2016): $3.8M, investors not publicly disclosed
Series A (2018): $6M led by Rethink Impact
Debt (2020): $150K supported by PPP
Debt (2021): $252K featuring PPP
Series B (2021): $6M backed by Atlantic Street Capital
Key Investors in Univfy
Atlantic Street Capital
An operationally focused private equity firm that partners with entrepreneurs to foster growth in lower middle market businesses through hands-on operational support.
Rethink Impact
A venture capital firm dedicated to investing in technology platforms that address significant global challenges and drive measurable social impact.
PPP
Public-Private Partnership
What's next for Univfy?
With the support of its latest capital injection, Univfy is poised to accelerate its market penetration and enhance its technological infrastructure. The strategic focus will likely center on scaling its predictive modeling capabilities to accommodate a broader range of fertility clinics and patient demographics. As the company matures, the integration of its analytics platform into standard clinical workflows will be critical for maintaining its competitive edge. Furthermore, the continued collaboration with institutional partners will enable Univfy to refine its financial products, ensuring that the company remains at the forefront of the fertility technology sector while addressing the evolving needs of patients and providers alike.
See full Univfy company page
